https://www.selleckchem.com/pr....oducts/Gemcitabine-H
Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder, which affects 4-10 % women of reproductive age. Though accumulating scientific evidence, its pathogenesis remains unclear. In the current study, metabolic profiling as well as diagnostic biomarkers for different phenotypes of PCOS was investigated using non-invasive urinary GCMS based metabolomics. A total of 371 subjects were recruited for the study. They constituted the following groups healthy women, those with hyperandrogenism (HA), wom
پسندیدن
اظهار نظر
اشتراک گذاری
